gamma-glutamylaminomethylsulfonic acid has been researched along with 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid in 5 studies
| Studies (gamma-glutamylaminomethylsulfonic acid) | Trials (gamma-glutamylaminomethylsulfonic acid) | Recent Studies (post-2010) (gamma-glutamylaminomethylsulfonic acid) | Studies (3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid) | Trials (3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid) | Recent Studies (post-2010) (3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid) |
|---|---|---|---|---|---|
| 52 | 0 | 2 | 755 | 2 | 65 |
| Protein | Taxonomy | gamma-glutamylaminomethylsulfonic acid (IC50) | 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.1139 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.1139 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.1139 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.1139 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.1139 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.1139 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.1139 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Hata, N; Nishikawa, T; Takahashi, K; Umino, A | 1 |
| Bradford, HF; Croucher, MJ; Sunter, DC; Watkins, JC | 1 |
| Ammendola, D; De Sarro, A; De Sarro, G; Nava, F | 1 |
| Abrahams, TP; Chen, K; Dasilva, AM; Gillis, RA; Hornby, PJ | 1 |
5 other study(ies) available for gamma-glutamylaminomethylsulfonic acid and 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Evidence for involvement of N-methyl-D-aspartate receptor in tonic inhibitory control of dopaminergic transmission in rat medial frontal cortex.
Topics: 2-Amino-5-phosphonovalerate; 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Cerebral Cortex; Dopamine; Glutamine; Infusions, Parenteral; Isomerism; Male; Methyltyrosines; N-Methylaspartate; Piperazines; Rats; Rats, Inbred Strains; Receptors, N-Methyl-D-Aspartate; Tyrosine 3-Monooxygenase | 1990 |
Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonists.
Topics: 2-Amino-5-phosphonovalerate; Amino Acids; Animals; Anticonvulsants; Cerebral Cortex; Electric Stimulation; Electrodes, Implanted; Electrophysiology; Glutamine; Injections; Kindling, Neurologic; Male; Piperazines; Rats; Rats, Inbred Strains | 1988 |
Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Animals; Anticonvulsants; Dizocilpine Maleate; Excitatory Amino Acids; Glutamine; Imipenem; Kynurenic Acid; Mice; Mice, Inbred DBA; Muscimol; Piperazines; Piperidines; Quinoxalines; Seizures | 1995 |
The non-NMDA subtype of excitatory amino acid receptor plays the major role in control of cardiovascular function by the subretrofacial nucleus in cats.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Blood Pressure; Cardiovascular Physiological Phenomena; Cats; Female; Glutamine; Kynurenic Acid; Male; Medulla Oblongata; Microinjections; Neurons; Piperazines; Quinoxalines; Receptors, Amino Acid; Receptors, N-Methyl-D-Aspartate | 1994 |